Dr. Giuseppe Leone is a distinguished hematology scholar and Editor-in-Chief of the Mediterranean Journal of Hematology and Infectious Diseases (MJHID), a position he has held since 2009. With over 15 years of experience, he has played a pivotal role in shaping the journal into a respected platform for disseminating high-quality research in hematology and infectious diseases. Under his leadership, MJHID has achieved an official Web of Science Impact Factor of 3.2 (2024), reflecting its growing academic influence. His expertise spans hematology, infectious diseases, internal medicine, statistics, and editorial management. Dr. Leone is committed to advancing scientific knowledge and fostering international collaboration among researchers and healthcare professionals. He has contributed extensively to scientific publications and has received several recognitions in his field. Fluent in English, French, and Italian, he actively engages with the global medical community.

Dr. Jorge E. Osorio DVM, MS, PhD,has had a lengthy career in medical sciences, ranging from virology, field epidemiological studies, vaccinology, antivirals, vector control programs, and global health. Dr. Osorio was the director of the Global Health Institute for UW-Madison between 2022-2025.He recently co-founded VaxThera, a Colombian-based company that will produce vaccines and biologicals for Colombia and the region.Dr. Osorio was also a co-founder and Chief Scientific Officer of Inviragen, LLC. This company developed a novel chimeric tetravalent dengue vaccine that completed Phase 3 clinical trials and is now commercially available in many countries. He also developed vaccines against chikungunya, Zika, influenza, rabies, plague,Nipah, yellow fever,and many other emerging infectious diseases. He has expertise in vaccine design and optimization of antigen expression, and has used mRNA, viral vectors, live attenuated, and recombinant protein expression systems to develop novel vaccines. Dr. Osorio was also the Vice-President of Research and Vice-President of Government Affairs for the Vaccine Business Division of Takeda Pharmaceuticals.Dr. Osorio worked for the World Mosquito Program and created business opportunities to implement Wolbachia as a strategy for vector control in several Latin American countries. His industry career also included positions at Heska Corporation (Ft. Collins, CO), Merial LTD (Athens, GA), and Chiron-Powderject Vaccines (Madison, WI). He has more than 35 years of research and industry experience, with over200 scientific publications in international journals and 33 patents.

Dr. Graeme Ladds has worked in the field of global Pharmacovigilance for the last 35 years. In that time he has worked with many different product types both in the clinical and post-marketing phase which has included vaccines since 1994. Graeme has developed a number of systems to enhance patient safety including for vaccines as well as ensuring that whatever the volumes of uptake globally for vaccines and for monitoring the data was accurate and complete.